Clinical Trial Update: "Prolonging the Therapeutic Life Span of Artemisinin-based Combination Therapies (ACT) in Bagamoyo District, Tanzania" [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial conducted in Tanzania aims to prolong the therapeutic life span of artemisinin-based combination therapies for falciparum malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falciparum Malaria
• Malaria

Drugs mentioned

• Artemisinin-based combination therapies (artemisinin-based combination therapy)

Snippet

Sponsor: Muhimbili University of Health and Allied Sciences | Conditions: Malaria,Falciparum | Phase 4 | Status: COMPLETED